Production, safety and antitumor efficacy of recombinant Oncofetal Antigen/immature laminin receptor protein.

[1]  Y. Doki,et al.  Analysis of peripheral and local anti‐tumor immune response in esophageal cancer patients after NY‐ESO‐1 protein vaccination , 2008, International journal of cancer.

[2]  M. Plebanski,et al.  Promising particle-based vaccines in cancer therapy , 2008, Expert review of vaccines.

[3]  Y. Doki,et al.  Antibody response against NY‐ESO‐1 in CHP‐NY‐ESO‐1 vaccinated patients , 2007, International journal of cancer.

[4]  Y. Perrie,et al.  A comparative study of cationic liposome and niosome‐based adjuvant systems for protein subunit vaccines: characterisation, environmental scanning electron microscopy and immunisation studies in mice , 2006, The Journal of pharmacy and pharmacology.

[5]  N. Schmitz,et al.  Identification of HLA-A*0201-Presented T Cell Epitopes Derived from the Oncofetal Antigen-Immature Laminin Receptor Protein in Patients with Hematological Malignancies , 2006, The Journal of Immunology.

[6]  A. Barsoum,et al.  Identification of Oncofetal Antigen/Immature Laminin Receptor Protein Epitopes That Activate BALB/c Mouse OFA/iLRP-Specific Effector and Regulatory T Cell Clones1 , 2006, The Journal of Immunology.

[7]  A. Barsoum,et al.  Contemporary definitions of tumor specific antigens, immunogens and markers as related to the adaptive responses of the cancer-bearing host. , 2005, Anticancer research.

[8]  A. Scott,et al.  Recombinant NY‐ESO‐1 Cancer Antigen: Production and Purification under cGMP Conditions , 2005, Preparative biochemistry & biotechnology.

[9]  Bernhard Fleischer,et al.  Lipopolysaccharide-free Heat Shock Protein 60 Activates T Cells* , 2004, Journal of Biological Chemistry.

[10]  M. Cheever,et al.  Effect of dose on immune response in patients vaccinated with an her-2/neu intracellular domain protein--based vaccine. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  N. Schmitz,et al.  Induction of cytotoxic T-cell responses against the oncofetal antigen-immature laminin receptor for the treatment of hematologic malignancies. , 2003, Blood.

[12]  S. Aamdal,et al.  Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2: a clinical report. , 2003, European journal of cancer.

[13]  G. Bartsch,et al.  Immunotherapy of metastatic renal cell carcinoma with tumor lysate-pulsed autologous dendritic cells. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[14]  G. Chikh,et al.  Liposomal Delivery of CTL Epitopes to Dendritic Cells , 2002, Bioscience reports.

[15]  Edgar G. Engleman,et al.  Dendritic Cells Injected Via Different Routes Induce Immunity in Cancer Patients1 , 2001, The Journal of Immunology.

[16]  A. Barsoum,et al.  37kDa oncofetal antigen is an autoimmunogenic homologue of the 37kDa laminin receptor precursor , 2000 .

[17]  J W Rohrer,et al.  37 kiloDalton oncofetal antigen protein and immature laminin receptor protein are identical, universal T-cell inducing immunogens on primary rodent and human cancers. , 1999, Anticancer research.

[18]  A. Barsoum,et al.  Human breast carcinoma patients develop clonable oncofetal antigen-specific effector and regulatory T lymphocytes. , 1999, Journal of immunology.

[19]  U. Rinas,et al.  Secretion-dependent proteolysis of heterologous protein by recombinant Escherichia coli is connected to an increased activity of the energy-generating dissimilatory pathway. , 1999, Biotechnology and bioengineering.

[20]  A. Barsoum,et al.  Tumors express both unique TSTA and crossprotective 44 kDa oncofetal antigen. , 1998, Immunology today.

[21]  S. Ménard,et al.  Formation of the 67‐kDa laminin receptor by acylation of the precursor , 1998, Journal of cellular biochemistry.

[22]  M. Reddish,et al.  Liposomal formulations of synthetic MUC1 peptides: effects of encapsulation versus surface display of peptides on immune responses. , 1998, Bioconjugate chemistry.

[23]  S. Ménard,et al.  New insights into the metastasis‐associated 67 kD laminin receptor , 1997, Journal of cellular biochemistry.

[24]  G. Jackowski,et al.  Removal of endotoxin from recombinant protein preparations. , 1997, Clinical Biochemistry.

[25]  E. Dratz,et al.  Studies of the structure of the metastasis-associated 67 kDa laminin binding protein: fatty acid acylation and evidence supporting dimerization of the 32 kDa gene product to form the mature protein. , 1995, Biochemistry.

[26]  A. Barsoum,et al.  Characterization of RFM mouse T lymphocyte anti-oncofetal antigen immunity in apparent tumor-free, long-term survivors of sublethal X-irradiation by limiting dilution T lymphocyte cloning. , 1995, Journal of immunology.

[27]  A. Barsoum,et al.  Differential recognition of murine tumor-associated oncofetal transplantation antigen and individually specific tumor transplantation antigens by syngeneic cloned BALB/c and RFM mouse T cells. , 1994, Journal of immunology.

[28]  R. Hester,et al.  44-kd oncofetal transplantation antigen in rodent and human fetal cells. Implications of recrudescence in human and rodent cancers. , 1993, Archives of otolaryngology--head & neck surgery.

[29]  Sobel Me.  Differential expression of the 67 kDa laminin receptor in cancer. , 1993 .

[30]  M. Sobel.  Differential expression of the 67 kDa laminin receptor in cancer. , 1993, Seminars in cancer biology.

[31]  T. Abe,et al.  Cloning of 67-kDa laminin receptor cDNA and gene expression in normal and malignant cell lines of the human lung. , 1992, Cancer letters.

[32]  T. R. Broker,et al.  Expression of high-affinity laminin receptor mRNA correlates with cell proliferation rather than invasion in human papillomavirus-associated cervical neoplasms. , 1992, Cancer research.

[33]  L. Liotta,et al.  Evidence for a precursor of the high-affinity metastasis-associated murine laminin receptor. , 1989, Biochemistry.

[34]  J. Wong,et al.  Increased mRNA expression of a laminin-binding protein in human colon carcinoma: complete sequence of a full-length cDNA encoding the protein. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[35]  R. Hester,et al.  Human squamous cell carcinoma lines express oncofetal 44‐kd polypeptide defined by monoclonal antibody to mouse fetus , 1988, Cancer.

[36]  W. Payne,et al.  Mouse monoclonal antibody to embryonic antigen: development, cross-reactivity with rodent and human tumors, and preliminary polypeptide characterization. , 1985, Journal of the National Cancer Institute.

[37]  L. Liotta,et al.  Laminin molecular domains which alter metastasis in a murine model. , 1984, The Journal of clinical investigation.

[38]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[39]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.